Key Statistics
Market Cap$17.08M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.79
52W High$2.46
52W Low$0.81
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+1.54%
3 Month-26.26%
1 Year+20.00%
FinancialsAnnual · QuiverQuant
Revenue$3.31M
Assets$17.13M
Liabilities$3.07M
Net Income$8.24M loss
About
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze MRKR with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.